coronavirus-disease-2019-covid-19

Documents about coronavirus-disease-2019-covid-19

• Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients#830009ClinicalTrials.gov
• Treatment With CSL312 in Adults With Coronavirus Disease 2019 (COVID-19)#1464409ClinicalTrials.gov
• Bone Marrow-Derived Mesenchymal Stem Cell Treatment for Severe Patients With Coronavirus Disease 2019 (COVID-19)#451509ClinicalTrials.gov
• Specimen Collection Study From Coronavirus Disease 2019 (COVID-19) Vaccinated Adults and Adolescents#886122ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of Prothione™ Capsules for Mild to Moderate Coronavirus Disease 2019 (COVID-19)#1452382ClinicalTrials.gov
• Evolution of Coronavirus Disease 2019 (COVID-19) Patients in Extremadura#1194805ClinicalTrials.gov
• Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors#1454546ClinicalTrials.gov
• Cytokine and Eicosanoid Mediators in Coronavirus Disease 2019 (COVID-19)#877385ClinicalTrials.gov
• Prognosis of Coronavirus Disease 2019 (COVID-19) Patients Receiving Receiving Antihypertensives#1047730ClinicalTrials.gov
• Clinical Study of Tanshinone Capsules Against COVID-19#123504ClinicalTrials.gov
• Convalescent Plasma for Patients With COVID-19: A Pilot Study#1377284ClinicalTrials.gov
• Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China#6835OpenAlex
• Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19)#1384201ClinicalTrials.gov
• A Study of How Ibuzatrelvir is Taken up Into the Blood of Healthy Adults After Taking Different Tablets of Ibuzatrelvir#879497ClinicalTrials.gov
• WHO Declares COVID-19 a Pandemic.#6166OpenAlex
• Sotrovimab Expanded Access Treatment Protocol (COVID-19)#864973ClinicalTrials.gov
• Safety and Immunogenicity Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime Boost Regimen for the Prevention of Coronavirus Disease 2019 (COVID-19)#857804ClinicalTrials.gov
• Retinal Vascular Changes in Patients After Coronavirus Disease 2019 (COVID-19)#826681ClinicalTrials.gov
• Immunogenicity After COVID-19 Vaccines in Adapted Schedules#1196427ClinicalTrials.gov
• Inhaled Interferon α2b for the Treatment of Coronavirus Disease 19 (COVID-19)#1293502ClinicalTrials.gov
• Convolutional Neural Network Model to Detect Coronavirus Disease 2019 (COVID-19) Pneumonia in Chest Radiographs#896267ClinicalTrials.gov
• Cutaneous Manifestations of Coronavirus Disease 2019(COVID-19).#885231ClinicalTrials.gov
• Silmitasertib (CX-4945) in Patients With Severe Coronavirus Disease 2019 (COVID-19)#1032935ClinicalTrials.gov
• An Observational Study of Patients With Coronavirus Disease 2019#829937ClinicalTrials.gov
• Safety of TY027, a Treatment for COVID-19, in Humans#830242ClinicalTrials.gov
• Clinical Characteristics and Prognostic Factors of Patients With COVID-19 (Coronavirus Disease 2019)#175006ClinicalTrials.gov
• Study of MK-4482 for Prevention of Coronavirus Disease 2019 (COVID-19) in Adults (MK-4482-013)#1009206ClinicalTrials.gov
• Study to Assess Adverse Events and How Intravenous (IV) ABBV-47D11 and IV ABBV-2B04 Given Alone and in Combination Moves Through the Body of Adult Participants With Coronavirus Disease 2019 (COVID-19)#1453853ClinicalTrials.gov
• ARVAC - A New Recombinant Coronavirus Disease 2019 (COVID-19) Vaccine#18691ClinicalTrials.gov
• Understanding COVID-19 Vaccine Immunity in Tissue and Blood#894909ClinicalTrials.gov
• A Phase 2 Trial of Infliximab in Coronavirus Disease 2019 (COVID-19).#1170943ClinicalTrials.gov
• LB1148 for Pulmonary Dysfunction Associated With COVID-19 Pneumonia#1029794ClinicalTrials.gov
• Assessment of N-95 Facemask for Use in COVID-19 Pandemic in Case of Shortage of Personal Protective Equipment#1444698ClinicalTrials.gov
• A Trial to Evaluate Safety and Efficacy of Rivaroxaban (COVID-19)#801954ClinicalTrials.gov
• A Study to Evaluate the Safety and Tolerability of AZD7442 in Chinese Adults#890794ClinicalTrials.gov
• Convalescent Plasma for Patients With COVID-19: A Randomized, Single Blinded, Parallel, Controlled Clinical Study#865225ClinicalTrials.gov
• Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS)#858179ClinicalTrials.gov
• Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine#6850OpenAlex
• WORKING FROM HOME: CYBERSECURITY IN THE AGE OF COVID-19#355293OpenAlex
• Law, structural racism, and the COVID-19 pandemic#416092OpenAlex
• Efficacy and Safety of TY027, a Treatment for COVID-19, in Humans#180207ClinicalTrials.gov
• Treatment of Severe Coronavirus Disease 2019 (COVID-19) With Convalescent Plasma#1096930ClinicalTrials.gov
• Neurologic Manifestations of COVID-19#1437098ClinicalTrials.gov
• Emerging Trends in Cybersecurity: Issues in Cybersecurity During Covid-19 Pandemic#1178826OpenAlex
• TD-0903 Pharmacokinetics Study in Healthy Participants With Supplemental Oxygenation#1031956ClinicalTrials.gov
• The Role of Blockchain to Fight Against COVID-19#215785OpenAlex
• A Novel Coronavirus from Patients with Pneumonia in China, 2019#6811OpenAlex
• The will to speak out: Medical anthropologist and patient in times of COVID-19 in Peru#1416656Repositorio Institucional de la PUCP
• The Universal Artificial Intelligence Efforts to Face Coronavirus COVID-19#964482OpenAlex
• How US law will evaluate artificial intelligence for covid-19#964484OpenAlex